CIK 0001868279 · Non-accelerated filer<br>Emerging growth company
ArriVent BioPharma, Inc.
Sign in to watch- Ticker
- AVBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 240-780-6356
- Business address
- 18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Operating Officer acquired 27,566 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 555,555 shares at $18.00 ($9,999,990)
- 4 Open-market buy Director bought 444,444 shares at $18.00 ($7,999,992)
- 4 Open-market buy Director bought 444,444 shares at $18.00 ($7,999,992)
- 4 Open-market buy Director bought 444,444 shares at $18.00 ($7,999,992)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 3 · 45 filings